NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mariposa Therapeutics

Mariposa Therapeutics

Private
CardiffHealthcare & Life Scienceshttps://mariposa.health/

Last Round

Seed

Mar 11, 2026

Total Funding Raised

$1M

Company Overview

Mariposa Therapeutics is a biotechnology company developing a first-in-class small molecule, MP5219, as a topical treatment for Epidermolysis Bullosa Simplex (EBS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales

AI Layer

Non-AI

Keywords

disease-modifying therapyEpidermolysis Bullosa SimplexEBSkeratin modulationsmall molecule therapyrare disease therapyfirst-in-class drugpreclinical biotechtopical drug deliveryorphan drug developmentdermatologygenetic skin disorderpharma licensingdrug discoveryIND-enabling studies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mariposa Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Mariposa Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mariposa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2026

Key People

Founding team and executive leadership

David Howat

Chief Executive Officer

Executive Team

Mariposa Therapeutics Investors

Notable investors and investment history

Mariposa Therapeutics investors
InvestorRounds
Development Bank of WalesSeed
DEBRA Research gGmbHSeed

Mariposa Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mariposa Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mariposa Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCardiff
Employee Range5
Year Founded2019
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.